Phibro Animal Health Corporation

Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets animal health products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products include antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics for treating infestations of parasitic intestinal worms; anti-bloat treatment products used in cattle to control bloat in animals grazing on legume, or wheat-pasture; and medicated feed additives and other related products. The company’s animal health products also comprise nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily in the poultry and swine industries. In addition, it manufactures and markets approximately formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds.

Type
Public
HQ
Teaneck, US
Founded
2003
Size (employees)
1,300 (est)+9%
Website
pahc.com
Phibro Animal Health Corporation was founded in 2003 and is headquartered in Teaneck, US

Phibro Animal Health Corporation Office Locations

Phibro Animal Health Corporation has an office in Teaneck
Teaneck, US (HQ)
500 Glenpointe Centre W

Phibro Animal Health Corporation Data and Metrics

Phibro Animal Health Corporation Financial Metrics

Phibro Animal Health Corporation's revenue was reported to be $189.9 m in Q3, 2017
USD

Revenue (Q3, 2017)

189.9 m

Gross profit (Q3, 2017)

60.6 m

Gross profit margin (Q3, 2017), %

32%

Net income (Q3, 2017)

49.2 m

EBIT (Q3, 2017)

30 m

Market capitalization (21-Jul-2017)

1.5 b

Cash (31-Mar-2017)

49.3 m
Phibro Animal Health Corporation's current market capitalization is $1.5 b.
USDFY, 2014FY, 2015FY, 2016

Revenue

691.9 m748.6 m751.5 m

Revenue growth, %

8%0%

Cost of goods sold

484.1 m512.2 m512.5 m

Gross profit

207.8 m236.4 m239 m

Gross profit Margin, %

30%32%32%

General and administrative expense

144 m148.7 m153.3 m

Operating expense total

144 m148.7 m153.3 m

EBIT

63.8 m87.7 m85.7 m

EBIT margin, %

9%12%11%

Interest expense

29.9 m14.6 m16.6 m

Pre tax profit

6.3 m78.8 m76.8 m

Income tax expense

9.4 m18.5 m(6 m)

Net Income

(3.1 m)60.3 m82.7 m
USDQ1, 2014Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017

Revenue

187.5 m188.7 m187.5 m187.1 m191.8 m183.5 m188 m191.6 m189.9 m

Cost of goods sold

127.1 m132.6 m128.4 m127 m129.4 m123.5 m127 m128.1 m129.2 m

Gross profit

60.3 m56.1 m59.1 m60.2 m62.4 m60 m61 m63.5 m60.6 m

Gross profit Margin, %

32%30%32%32%33%33%32%33%32%

General and administrative expense

35.2 m36.3 m37.3 m38.3 m39.8 m38.8 m39.2 m40.9 m30.6 m

Operating expense total

35.2 m36.3 m37.3 m38.3 m39.8 m38.8 m39.2 m40.9 m30.6 m

EBIT

25.1 m19.8 m21.8 m21.9 m22.6 m21.2 m21.8 m22.6 m30 m

EBIT margin, %

13%10%12%12%12%12%12%12%16%

Interest expense

3.6 m3.6 m3.7 m3.8 m4 m4.3 m3.9 m3.9 m3.9 m

Pre tax profit

22.8 m17.3 m22.8 m23.5 m16.1 m19.1 m17.6 m19.3 m26.4 m

Income tax expense

2.3 m1.9 m3.4 m4.7 m(14.1 m)572 k5.4 m5.9 m2.8 m

Net Income

20.5 m35.9 m55.3 m18.8 m48.9 m67.5 m12.2 m25.6 m49.2 m
USDFY, 2014FY, 2015FY, 2016

Cash

11.8 m29.2 m33.6 m

Accounts Receivable

113.9 m111.1 m123.8 m

Inventories

30.4 m23.6 m5.2 m

Current Assets

299.3 m313.7 m342.8 m

PP&E

109.2 m104.4 m127.3 m

Goodwill

21.1 m

Total Assets

472.3 m493.3 m610.4 m

Accounts Payable

59.6 m63.1 m60.2 m

Total Debt

289.4 m286.5 m283.7 m

Current Liabilities

112.4 m111.3 m108.7 m

Total Liabilities

519.9 m

Additional Paid-in Capital

132.5 m118.2 m118.3 m

Retained Earnings

(97.2 m)(37 m)34 m

Total Equity

15.1 m29.6 m90.5 m

Debt to Equity Ratio

19.1 x9.7 x3.1 x

Debt to Assets Ratio

0.6 x0.6 x0.5 x

Financial Leverage

31.2 x16.7 x6.7 x
USDQ1, 2014Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017

Cash

19.7 m31.8 m25.4 m32.2 m37.4 m39.2 m49.3 m

Accounts Receivable

110.8 m113.7 m114.6 m116.2 m119.6 m124.1 m113.1 m

Inventories

146.4 m147.3 m154.4 m168.3 m162.6 m158.8 m163.8 m

Current Assets

303.9 m317 m310.2 m332.6 m339.8 m339 m347.5 m

PP&E

105.4 m103.7 m112.9 m123.1 m127.3 m127.2 m127.2 m

Goodwill

21.1 m21.1 m21.1 m

Total Assets

470.8 m493.5 m521.5 m589.9 m598.1 m592.3 m602.3 m

Accounts Payable

64.5 m59.5 m61.2 m51.9 m54.3 m54.8 m53.3 m

Current Liabilities

106.8 m108.3 m114.5 m99.8 m101.3 m103.3 m106.3 m

Additional Paid-in Capital

128.6 m115 m116.4 m118.2 m118.3 m118.4 m120.9 m

Retained Earnings

(76.8 m)(18.2 m)8 m22.7 m42.2 m51.7 m71.4 m

Total Equity

21.6 m22.6 m53.3 m77.7 m102.3 m112.6 m139.4 m

Financial Leverage

21.8 x21.8 x9.8 x7.6 x5.8 x5.3 x4.3 x
USDFY, 2014FY, 2015FY, 2016

Net Income

(3.1 m)60.3 m82.7 m

Depreciation and Amortization

21.5 m21.6 m23.5 m

Accounts Receivable

(14.7 m)(1.9 m)(13.1 m)

Inventories

(31 k)7.4 m(6.9 m)

Accounts Payable

1.7 m4.8 m(3.2 m)

Cash From Operating Activities

(712 k)68.7 m37.2 m

Capital Expenditures

(19.8 m)(20.1 m)(36.4 m)

Dividends Paid

(25 m)(15.6 m)(15.7 m)

Cash From Financing Activities

4.8 m(15.4 m)50.4 m

Interest Paid

45.4 m12.9 m14.2 m

Free Cash Flow

(20.6 m)48.6 m866 k
USDY, 2017

Revenue/Employee

146 k

Financial Leverage

4.3 x

Phibro Animal Health Corporation Operating Metrics

Phibro Animal Health Corporation's Customers was reported to be 3 k in FY, 2016, which is a 3% increase from the previous period
FY, 2015FY, 2016

Customers

2.9 k3 k

Phibro Animal Health Corporation Market Value History

Phibro Animal Health Corporation Company Life and Culture

You may also be interested in